Activation of KCNQ4 as a Therapeutic Strategy to Treat Hearing Loss.

Rim, John Hoon; Choi, Jae Young; Jung, Jinsei; Gee, Heon Yung

Rim, John Hoon; Choi, Jae Young; Jung, Jinsei; Gee, Heon Yung.

Afiliação

Rim JH; Department of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Korea.
Choi JY; Department of Otorhinolaryngology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Korea.
Jung J; Department of Otorhinolaryngology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Korea.
Gee HY; Department of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Korea.

Int J Mol Sci ; 22(5)2021 Mar 02.

Article em En | MEDLINE | ID: mdl-33801540

Assuntos

Perda Auditiva/patologia; Canais de Potássio KCNQ/genética; Mutação; Animais; Perda Auditiva/genética; Perda Auditiva/terapia; Humanos

Palavras-chave

KCNQ4 activator; hearing loss; nonsyndromic hearing loss; potassium; potassium voltage-gated channel subfamily q member 4

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canais de Potássio KCNQ / Perda Auditiva / Mutação Limite: Animals / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google